147 related articles for article (PubMed ID: 30333885)
1. Histone deacetylase inhibitors sensitize 5-fluorouracil-resistant MDA-MB-468 breast cancer cells to 5-fluorouracil.
Minegaki T; Suzuki A; Mori M; Tsuji S; Yamamoto S; Watanabe A; Tsuzuki T; Tsunoda T; Yamamoto A; Tsujimoto M; Nishiguchi K
Oncol Lett; 2018 Nov; 16(5):6202-6208. PubMed ID: 30333885
[TBL] [Abstract][Full Text] [Related]
2. Deficient expression of the DPD gene is caused by epigenetic modification in biliary tract cancer cells, and induces high sensitivity to 5-FU treatment.
Sato K; Kitajima Y; Miyoshi A; Koga Y; Miyazaki K
Int J Oncol; 2006 Aug; 29(2):429-35. PubMed ID: 16820886
[TBL] [Abstract][Full Text] [Related]
3. The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil.
Li LH; Dong H; Zhao F; Tang J; Chen X; Ding J; Men HT; Luo WX; Du Y; Ge J; Tan BX; Cao D; Liu JY
Eur J Cancer; 2013 May; 49(7):1752-60. PubMed ID: 23313143
[TBL] [Abstract][Full Text] [Related]
4. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil.
Beck A; Etienne MC; Chéradame S; Fischel JL; Formento P; Renée N; Milano G
Eur J Cancer; 1994; 30A(10):1517-22. PubMed ID: 7833111
[TBL] [Abstract][Full Text] [Related]
5. Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer.
Griffith M; Mwenifumbo JC; Cheung PY; Paul JE; Pugh TJ; Tang MJ; Chittaranjan S; Morin RD; Asano JK; Ally AA; Miao L; Lee A; Chan SY; Taylor G; Severson T; Hou YC; Griffith OL; Cheng GS; Novik K; Moore R; Luk M; Owen D; Brown CJ; Morin GB; Gill S; Tai IT; Marra MA
Pharmacogenomics J; 2013 Apr; 13(2):148-58. PubMed ID: 22249354
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR.
Sagara A; Igarashi K; Otsuka M; Karasawa T; Gotoh N; Narita M; Kuzumaki N; Narita M; Kato Y
PLoS One; 2016; 11(10):e0164250. PubMed ID: 27723829
[TBL] [Abstract][Full Text] [Related]
7. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
[TBL] [Abstract][Full Text] [Related]
8. [Application of non-steroidal anti-inflammatory drugs to enhance 5-fluorouracil efficacy in experimental systems].
Réti A
Magy Onkol; 2010 Dec; 54(4):377-81. PubMed ID: 21163769
[TBL] [Abstract][Full Text] [Related]
9. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
10. Novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cells with dihydropyrimidine dehydrogenase overexpression.
Kikuchi O; Ohashi S; Nakai Y; Nakagawa S; Matsuoka K; Kobunai T; Takechi T; Amanuma Y; Yoshioka M; Ida T; Yamamoto Y; Okuno Y; Miyamoto S; Nakagawa H; Matsubara K; Chiba T; Muto M
Am J Cancer Res; 2015; 5(8):2431-40. PubMed ID: 26396918
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test.
Kakimoto M; Uetake H; Osanai T; Shirota Y; Takagi Y; Takeshita E; Toriya Y; Danenberg K; Danenberg PV; Sugihara K
Cancer Lett; 2005 Jun; 223(1):103-11. PubMed ID: 15890242
[TBL] [Abstract][Full Text] [Related]
12. Uricase sensitizes hepatocellular carcinoma cells to 5-fluorouracil through uricase-uric acid-UMP synthase axis.
Yu S; Li Z; Tu L; Pu Y; Yan D; Wang X; Zheng X; Yu J
J Physiol Biochem; 2022 Aug; 78(3):679-687. PubMed ID: 35674867
[TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
[TBL] [Abstract][Full Text] [Related]
14. Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitor.
Fischel JL; Formento P; Etienne MC; Spector T; Renée N; Milano G
Biochem Pharmacol; 1997 Jun; 53(11):1703-9. PubMed ID: 9264323
[TBL] [Abstract][Full Text] [Related]
15. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.
Banerjee D; Mayer-Kuckuk P; Capiaux G; Budak-Alpdogan T; Gorlick R; Bertino JR
Biochim Biophys Acta; 2002 Jul; 1587(2-3):164-73. PubMed ID: 12084458
[TBL] [Abstract][Full Text] [Related]
16. Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines.
Iwahashi S; Ishibashi H; Utsunomiya T; Morine Y; Ochir TL; Hanaoka J; Mori H; Ikemoto T; Imura S; Shimada M
J Med Invest; 2011 Feb; 58(1-2):106-9. PubMed ID: 21372494
[TBL] [Abstract][Full Text] [Related]
17. The role of dihydropyrimidine dehydrogenase expression in resistance to 5-fluorouracil in head and neck squamous cell carcinoma cells.
Yasumatsu R; Nakashima T; Uryu H; Masuda M; Hirakawa N; Shiratsuchi H; Tomita K; Fukushima M; Komune S
Oral Oncol; 2009 Feb; 45(2):141-7. PubMed ID: 18620897
[TBL] [Abstract][Full Text] [Related]
18. Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.
Nishiyama M; Yamamoto W; Park JS; Okamoto R; Hanaoka H; Takano H; Saito N; Matsukawa M; Shirasaka T; Kurihara M
Clin Cancer Res; 1999 Sep; 5(9):2620-8. PubMed ID: 10499641
[TBL] [Abstract][Full Text] [Related]
19. Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer.
Yu Z; Yang Q; Sun J; Zhen J
Exp Oncol; 2007 Sep; 29(3):192-6. PubMed ID: 18004243
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.
Fischel JL; Etienne MC; Spector T; Formento P; Renée N; Milano G
Clin Cancer Res; 1995 Sep; 1(9):991-6. PubMed ID: 9816071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
